RB1 and neuroendocrine carcinoma: As most NEC cases (7/13, 54%) were found to be triple‐negative in the study by Bean et al [10], we would like to share our findings of NE biomarker expression with p53 aberrant staining and Rb protein loss in a cohort of 73 TNBC cases.